Lobularni karcinom in situ (Slovenian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Lobularni karcinom in situ" in Slovenian language version.

refsWebsite

Global rank Slovenian rank

11nih.gov

4^th place

8^th place

9doi.org

2^nd place

5^th place

4semanticscholar.org

11^th place

51^st place

2cancer.gov

1,684^th place

381^st place

2archive.org

6^th place

9^th place

1termania.net

low place

34^th place

1stanford.edu

179^th place

154^th place

1mayoclinic.com

3,634^th place

1,010^th place

1cancerstaging.org

low place

1mayoclinic.org

1,610^th place

418^th place

1ukc-mb.si

low place

1,098^th place

archive.org

American Joint Committee on Cancer (2002). AJCC cancer staging handbook : from the AJCC cancer staging manual (6th izd.). New York: Springer. str. 260. ISBN 9780387952703.
Cotran RS, Kumar V, Fausto N, Robbins SL, Abbas AK (2005). Robbins and Cotran pathologic basis of disease (7th izd.). St. Louis, MO: Elsevier Saunders. str. 1142. ISBN 978-0-7216-0187-8.

cancer.gov

»Breast Cancer Treatment«. National Cancer Institute. 27. maj 2022.
»Breast Cancer Treatment (PDQ®) - National Cancer Institute - Lobular Carcinoma In Situ«. Pridobljeno 12. januarja 2013.

cancerstaging.org

AJCC Cancer Staging Manual, Eighth Edition - Part XI - Breast (PDF). The American College of Surgeons. 2018. str. 590.

doi.org

Collins LC (Marec 2018). »Precursor Lesions of the Low-Grade Breast Neoplasia Pathway«. Surgical Pathology Clinics. 11 (1): 177–197. doi:10.1016/j.path.2017.09.007. PMID 29413656.
Afonso N, Bouwman D (Avgust 2008). »Lobular carcinoma in situ«. European Journal of Cancer Prevention. 17 (4): 312–316. doi:10.1097/CEJ.0b013e3282f75e5d. PMID 18562954. S2CID 388045.
Logan GJ, Dabbs DJ, Lucas PC, Jankowitz RC, Brown DD, Clark BZ, in sod. (Junij 2015). »Molecular drivers of lobular carcinoma in situ«. Breast Cancer Research. 17: 76. doi:10.1186/s13058-015-0580-5. PMC 4453073. PMID 26041550.
Canas-Marques R, Schnitt SJ (Januar 2016). »E-cadherin immunohistochemistry in breast pathology: uses and pitfalls«. Histopathology. 68 (1): 57–69. doi:10.1111/his.12869. PMID 26768029. S2CID 19569431.
Jorns J, Sabel MS, Pang JC (Oktober 2014). »Lobular neoplasia: morphology and management«. Archives of Pathology & Laboratory Medicine. 138 (10): 1344–1349. doi:10.5858/arpa.2014-0278-CC. PMID 25268198.
Wen HY, Brogi E (Marec 2018). »Lobular Carcinoma In Situ«. Surgical Pathology Clinics. 11 (1): 123–145. doi:10.1016/j.path.2017.09.009. PMC 5841603. PMID 29413653.
King TA, Reis-Filho JS (Julij 2014). »Lobular neoplasia«. Surgical Oncology Clinics of North America. 23 (3): 487–503. doi:10.1016/j.soc.2014.03.002. PMID 24882347. S2CID 31630480.
Page DL, Schuyler PA, Dupont WD, Jensen RA, Plummer WD, Simpson JF (Januar 2003). »Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study«. Lancet. 361 (9352): 125–129. doi:10.1016/S0140-6736(03)12230-1. PMID 12531579. S2CID 6429291.
Xie ZM, Sun J, Hu ZY, Wu YP, Liu P, Tang J, in sod. (september 2017). »Survival outcomes of patients with lobular carcinoma in situ who underwent bilateral mastectomy or partial mastectomy«. European Journal of Cancer. 82: 6–15. doi:10.1016/j.ejca.2017.05.030. PMID 28646773.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)

mayoclinic.com

»Lobular carcinoma in situ: Marker for breast cancer risk«. MayoClinic.com.

mayoclinic.org

https://www.mayoclinic.org/diseases-conditions/lobular-carcinoma-in-situ/diagnosis-treatment/drc-20374535, vpogled: 14. 9. 2022.

nih.gov

pubmed.ncbi.nlm.nih.gov

Collins LC (Marec 2018). »Precursor Lesions of the Low-Grade Breast Neoplasia Pathway«. Surgical Pathology Clinics. 11 (1): 177–197. doi:10.1016/j.path.2017.09.007. PMID 29413656.
Afonso N, Bouwman D (Avgust 2008). »Lobular carcinoma in situ«. European Journal of Cancer Prevention. 17 (4): 312–316. doi:10.1097/CEJ.0b013e3282f75e5d. PMID 18562954. S2CID 388045.
Logan GJ, Dabbs DJ, Lucas PC, Jankowitz RC, Brown DD, Clark BZ, in sod. (Junij 2015). »Molecular drivers of lobular carcinoma in situ«. Breast Cancer Research. 17: 76. doi:10.1186/s13058-015-0580-5. PMC 4453073. PMID 26041550.
Canas-Marques R, Schnitt SJ (Januar 2016). »E-cadherin immunohistochemistry in breast pathology: uses and pitfalls«. Histopathology. 68 (1): 57–69. doi:10.1111/his.12869. PMID 26768029. S2CID 19569431.
Jorns J, Sabel MS, Pang JC (Oktober 2014). »Lobular neoplasia: morphology and management«. Archives of Pathology & Laboratory Medicine. 138 (10): 1344–1349. doi:10.5858/arpa.2014-0278-CC. PMID 25268198.
Wen HY, Brogi E (Marec 2018). »Lobular Carcinoma In Situ«. Surgical Pathology Clinics. 11 (1): 123–145. doi:10.1016/j.path.2017.09.009. PMC 5841603. PMID 29413653.
King TA, Reis-Filho JS (Julij 2014). »Lobular neoplasia«. Surgical Oncology Clinics of North America. 23 (3): 487–503. doi:10.1016/j.soc.2014.03.002. PMID 24882347. S2CID 31630480.
Page DL, Schuyler PA, Dupont WD, Jensen RA, Plummer WD, Simpson JF (Januar 2003). »Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study«. Lancet. 361 (9352): 125–129. doi:10.1016/S0140-6736(03)12230-1. PMID 12531579. S2CID 6429291.
Xie ZM, Sun J, Hu ZY, Wu YP, Liu P, Tang J, in sod. (september 2017). »Survival outcomes of patients with lobular carcinoma in situ who underwent bilateral mastectomy or partial mastectomy«. European Journal of Cancer. 82: 6–15. doi:10.1016/j.ejca.2017.05.030. PMID 28646773.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)

ncbi.nlm.nih.gov

Logan GJ, Dabbs DJ, Lucas PC, Jankowitz RC, Brown DD, Clark BZ, in sod. (Junij 2015). »Molecular drivers of lobular carcinoma in situ«. Breast Cancer Research. 17: 76. doi:10.1186/s13058-015-0580-5. PMC 4453073. PMID 26041550.
Wen HY, Brogi E (Marec 2018). »Lobular Carcinoma In Situ«. Surgical Pathology Clinics. 11 (1): 123–145. doi:10.1016/j.path.2017.09.009. PMC 5841603. PMID 29413653.

semanticscholar.org

api.semanticscholar.org

Afonso N, Bouwman D (Avgust 2008). »Lobular carcinoma in situ«. European Journal of Cancer Prevention. 17 (4): 312–316. doi:10.1097/CEJ.0b013e3282f75e5d. PMID 18562954. S2CID 388045.
Canas-Marques R, Schnitt SJ (Januar 2016). »E-cadherin immunohistochemistry in breast pathology: uses and pitfalls«. Histopathology. 68 (1): 57–69. doi:10.1111/his.12869. PMID 26768029. S2CID 19569431.
King TA, Reis-Filho JS (Julij 2014). »Lobular neoplasia«. Surgical Oncology Clinics of North America. 23 (3): 487–503. doi:10.1016/j.soc.2014.03.002. PMID 24882347. S2CID 31630480.
Page DL, Schuyler PA, Dupont WD, Jensen RA, Plummer WD, Simpson JF (Januar 2003). »Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study«. Lancet. 361 (9352): 125–129. doi:10.1016/S0140-6736(03)12230-1. PMID 12531579. S2CID 6429291.

stanford.edu

cancer.stanford.edu

»Lobular Carcinoma in situ (LCIS)«. Breast Cancer. Stanford Cancer Center.

termania.net

https://www.termania.net/slovarji/slovenski-medicinski-slovar/5521966/karcinom?query=Karcinom&SearchIn=All, Slovenski medicinski e-slovar, vpogled: 12. 9. 2022.

ukc-mb.si

https://www.ukc-mb.si/torakalna/rak-dojke/4-vrste-raka-dojk, vpogled: 14. 9. 2022.